This study introduces a novel imaging system utilizing Cerenkov luminescence microscopy (CLM) to visualize the activity of radioactive tracers in 3D tumor spheroids. The system integrates an EMCCD camera, a microscope objective, and a precise sample positioning setup, enabling the high-resolution detection of Cerenkov light emission from radiotracers in a light-tight environment. The characteristics of the new CLM system have been tested on glioblastoma multiforme (GLM) spheroids, subjected or not to X-ray radiotherapy. The system effectively differentiated irradiated from non-irradiated spheroids by detecting distinct variations in signal intensity, which were further validated through comparison with autoradiography and quantitative activity measurements. This demonstrates the system's ability to provide highly sensitive imaging of radiolabeled biological samples. The method offers new possibilities for studying radiopharmaceutical distribution and metabolic processes at the cellular level, making it a valuable tool for advancing both diagnostic and therapeutic radiopharmaceutical development, as well as for evaluating treatment efficacy.

Cerenkov luminescence microscopy: A novel approach for high-resolution radiotracer imaging

Alborghetti, Lisa;Vurro, Federica;Lacavalla, Maria Assunta;Boschi, Federico;
2025-01-01

Abstract

This study introduces a novel imaging system utilizing Cerenkov luminescence microscopy (CLM) to visualize the activity of radioactive tracers in 3D tumor spheroids. The system integrates an EMCCD camera, a microscope objective, and a precise sample positioning setup, enabling the high-resolution detection of Cerenkov light emission from radiotracers in a light-tight environment. The characteristics of the new CLM system have been tested on glioblastoma multiforme (GLM) spheroids, subjected or not to X-ray radiotherapy. The system effectively differentiated irradiated from non-irradiated spheroids by detecting distinct variations in signal intensity, which were further validated through comparison with autoradiography and quantitative activity measurements. This demonstrates the system's ability to provide highly sensitive imaging of radiolabeled biological samples. The method offers new possibilities for studying radiopharmaceutical distribution and metabolic processes at the cellular level, making it a valuable tool for advancing both diagnostic and therapeutic radiopharmaceutical development, as well as for evaluating treatment efficacy.
2025
Applied sciences
Medical imaging
File in questo prodotto:
File Dimensione Formato  
2025_Alborghetti_1-s2.0-S2589004225021017-main.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 19.09 MB
Formato Adobe PDF
19.09 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1190995
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact